Tolerability and outcome of sunitinib by giving 4/2 schedule versus 2/1 schedule in metastatic renal cell carcinoma patients: a prospective randomized multi-centric Egyptian study
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Termedia Publishing House
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/fa35fde7f1a7446d9d954c25e26d2d8f |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|